Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Quercetin: a potential natural drug for adjuvant treatment of rheumatoid arthritis.

Ji JJ, Lin Y, Huang SS, Zhang HL, Diao YP, Li K.

Afr J Tradit Complement Altern Med. 2013 Apr 12;10(3):418-21. eCollection 2013.

2.

Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.

Plum SM, Park EJ, Strawn SJ, Moore EG, Sidor CF, Fogler WE.

BMC Musculoskelet Disord. 2009 May 1;10:46. doi: 10.1186/1471-2474-10-46.

3.

Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat.

Huang J, Zhu M, Tao Y, Wang S, Chen J, Sun W, Li S.

J Pharm Pharmacol. 2012 Aug;64(8):1119-27. doi: 10.1111/j.2042-7158.2012.01504.x. Epub 2012 Mar 22.

PMID:
22775215
4.

Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.

Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, Shimada K, Kamatani N.

Arthritis Rheum. 2004 Jul;50(7):2167-77.

5.

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis.

Konisti S, Kiriakidis S, Paleolog EM.

Nat Rev Rheumatol. 2012 Jan 31;8(3):153-62. doi: 10.1038/nrrheum.2011.205. Review.

PMID:
22293762
6.

Is Taurolidine a candidate for treatment of rheumatoid arthritis?

Marcinkiewicz J, Głuszko P, Kontny E, Kwaśny-Krochin B, Bobek M, Wierzchowski W, Ciszek M, Maśliński W.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):211-8.

PMID:
17543144
7.

The suppressive effects of Saposhnikovia divaricata (Fangfeng) chromone extract on rheumatoid arthritis via inhibition of nuclear factor-κB and mitogen activated proteinkinases activation on collagen-induced arthritis model.

Kong X, Liu C, Zhang C, Zhao J, Wang J, Wan H, Zhu H, Zhang P, Chen W, Xiao Y, Lin N.

J Ethnopharmacol. 2013 Jul 30;148(3):842-50. doi: 10.1016/j.jep.2013.05.023. Epub 2013 May 25.

PMID:
23711830
8.

Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.

Tas SW, Vervoordeldonk MJ, Hajji N, May MJ, Ghosh S, Tak PP.

Arthritis Res Ther. 2006;8(4):R86.

9.

Mangiferin: A promising therapeutic agent for rheumatoid arthritis treatment.

Luczkiewicz P, Kokotkiewicz A, Dampc A, Luczkiewicz M.

Med Hypotheses. 2014 Nov;83(5):570-4. doi: 10.1016/j.mehy.2014.08.021. Epub 2014 Aug 24.

PMID:
25204703
10.

Active compound of Zingiber cassumunar Roxb. down-regulates the expression of genes involved in joint erosion in a human synovial fibroblast cell line.

Chaiwongsa R, Ongchai S, Boonsing P, Kongtawelert P, Panthong A, Reutrakul V.

Afr J Tradit Complement Altern Med. 2012 Oct 1;10(1):40-8. eCollection 2012.

11.

SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage.

Xie C, Ma L, Liu J, Li X, Pei H, Xiang M, Chen L.

PLoS One. 2013;8(2):e56349. doi: 10.1371/journal.pone.0056349. Epub 2013 Feb 19.

12.

Wen Luo Yin inhibits angiogenesis in collagen-induced arthritis rat model and in vitro.

Liu C, Kong X, Li X, Guo W, Zhang C, Sun Y, Su X, Liu X, Lu A, Lin N.

J Ethnopharmacol. 2013 Sep 16;149(2):478-89. doi: 10.1016/j.jep.2013.07.002. Epub 2013 Jul 16.

PMID:
23872253
13.
14.

Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis.

Okamoto H, Yoshio T, Kaneko H, Yamanaka H.

Arthritis Rheum. 2010 Jan;62(1):82-92. doi: 10.1002/art.25063.

15.

Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors.

Yarilina A, Xu K, Chan C, Ivashkiv LB.

Arthritis Rheum. 2012 Dec;64(12):3856-66. doi: 10.1002/art.37691.

16.

Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis.

Okamoto H, Iwamoto T, Kotake S, Momohara S, Yamanaka H, Kamatani N.

Clin Exp Rheumatol. 2005 May-Jun;23(3):323-30.

PMID:
15971419
17.

NF-kappa B activation in human knee-joint synovial tissue during the early stage of joint inflammation.

Gilston V, Jones HW, Soo CC, Coumbe A, Blades S, Kaltschmidt C, Baeuerle PA, Morris CJ, Blake DR, Winyard PG.

Biochem Soc Trans. 1997 Aug;25(3):518S. No abstract available.

PMID:
9388734
18.

Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis.

Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE, Dubois LG, Huang KH, Mabbett SR, Silinski MA, Steed PM, Hall SE.

Arthritis Rheum. 2008 Dec;58(12):3765-75. doi: 10.1002/art.24047.

19.

Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models.

Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, Park DS.

Int Immunopharmacol. 2009 Mar;9(3):268-76. doi: 10.1016/j.intimp.2008.11.005. Epub 2008 Dec 25.

PMID:
19111632
20.
Items per page

Supplemental Content

Write to the Help Desk